Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 2.930
+0.075 (2.63%)
Jul 3, 2026, 5:29 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 195.54 million as of July 2, 2026. Its market cap has decreased by -25.67% in one year.
Market Cap
195.54M
Enterprise Value
177.67M
Revenue
10.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.93
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 195.54M, an increase of 59.43%. That is a compound annual growth rate of 9.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 195.54M | -22.82% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 241.97M |
| Xbrane Biopharma AB | 215.33M |
| Initiator Pharma | 184.82M |
| Xintela AB | 175.70M |
| Diamyd Medical AB | 158.08M |
| Nanologica AB | 157.81M |
| Active Biotech AB | 148.41M |
| Simris Group AB (PUBL) | 132.01M |